Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology by Stephen M. Stahl

Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology by Stephen M. Stahl

Author:Stephen M. Stahl
Language: eng
Format: mobi
Publisher: Cambridge University Press
Published: 2014-09-24T21:00:00+00:00


Lofepramine

Lofepramine: THERAPEUTICS

Brands

• Deprimyl

• Gamanil

see index for additional brand names

Generic?

Yes

Class

• Tricyclic antidepressant (TCA)

• Predominantly a norepinephrine/noradrenaline reuptake inhibitor

Commonly Prescribed for

(bold for FDA approved)

• Major depressive disorder

• Anxiety

• Insomnia

• Neuropathic pain/chronic pain

• Treatment-resistant depression

How the Drug Works

• Boosts neurotransmitter norepinephrine/noradrenaline

• Blocks norepinephrine reuptake pump (norepinephrine transporter), presumably increasing noradrenergic neurotransmission

• Since dopamine is inactivated by norepinephrine reuptake in frontal cortex, which largely lacks dopamine transporters, lofepramine can increase dopamine neurotransmission in this part of the brain

• A more potent inhibitor of norepinephrine reuptake pump than serotonin reuptake pump (serotonin transporter)

• At high doses may also boost neurotransmitter serotonin and presumably increase serotonergic neurotransmission

How Long Until It Works

• May have immediate effects in treating insomnia or anxiety

• Onset of therapeutic actions usually not immediate, but often delayed 2–4 weeks

• If it is not working within 6–8 weeks for depression, it may require a dosage increase or it may not work at all

• May continue to work for many years to prevent relapse of symptoms

If It Works

• The goal of treatment of depression is complete remission of current symptoms as well as prevention of future relapses

• The goal of treatment of chronic neuropathic pain is to reduce symptoms as much as possible, especially in combination with other treatments

• Treatment of depression most often reduces or even eliminates symptoms, but not a cure since symptoms can recur after medicine stopped

• Treatment of chronic neuropathic pain may reduce symptoms, but rarely eliminates them completely, and is not a cure since symptoms can recur after medicine is stopped

• Continue treatment of depression until all symptoms are gone (remission)

• Once symptoms of depression are gone, continue treating for 1 year for the first episode of depression

• For second and subsequent episodes of depression, treatment may need to be indefinite

• Use in anxiety disorders and chronic pain may also need to be indefinite, but long-term treatment is not well studied in these conditions

If It Doesn’t Work

• Many depressed patients have only a partial response where some symptoms are improved but others persist (especially insomnia, fatigue, and problems concentrating)

• Other depressed patients may be nonresponders, sometimes called treatment-resistant or treatment-refractory

• Consider increasing dose, switching to another agent or adding an appropriate augmenting agent

• Consider psychotherapy

• Consider evaluation for another diagnosis or for a comorbid condition (e.g., medical illness, substance abuse, etc.)

• Some patients may experience apparent lack of consistent efficacy due to activation of latent or underlying bipolar disorder, and require antidepressant discontinuation and a switch to a mood stabilizer



Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.